Concepedia

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically

Primo N. Lara, David R. Gandara, Gregory T. Wurz, Derick Lau, Margaret Uhrich, Corinne Turrell, James Raschko, Martin J. Edelman, Timothy W. Synold, James Doroshow,

Cancer Chemotherapy and Pharmacology · 1998 · 11 citations · 9 references

DOI

Concepts

References

9

Inhibition of protein kinase C by tamoxifen.

C A O'Brian, Rob M. J. Liskamp, David H. Solomon et al. · PubMed · 1985 · 468 citations · Full text

, , +10

Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer.

D F Hayes, J. A. Van Zyl, A Hacking et al. · Journal of Clinical Oncology · 1995 · 220 citations

, , +16

Triphenylethylenes: A New Class of Protein Kinase C Inhibitors

C A O'Brian, Rob M. J. Liskamp, David H. Solomon et al. · JNCI Journal of the National Cancer Institute · 1986 · 136 citations

, , +10

Clinical pharmacology of tamoxifen in patients with breast cancer: comparison of traditional and loading dose schedules.

新薬と臨床 · 1981 · 81 citations

, , +16

Modulation of cisplatin resistance in human malignant melanoma cells.

Edward F. McClay, Kathleen D. Albright, Jeffrey A. Jones et al. · PubMed · 1992 · 60 citations

, , +17